Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
Front Endocrinol (Lausanne) ; 15: 1413519, 2024.
Article in English | MEDLINE | ID: mdl-38706695

ABSTRACT

[This corrects the article DOI: 10.3389/fendo.2024.1294638.].

3.
Article in English | MEDLINE | ID: mdl-38809741

ABSTRACT

This study proposes a neural-network (NN)-based adaptive fixed-time control method for a two-degree-of-freedom (2-DOF) nonlinear helicopter system with input quantization and output constraints. First, a hysteresis quantizer is employed to mitigate chattering during signal quantization, and adaptive variables are utilized to eliminate errors in the quantization process. Subsequently, the system uncertainties are approximated using a radial basis function NN. Simultaneously, a logarithmic barrier Lyapunov function (BLF) is constructed to prevent the system outputs from violating the constraint boundaries. Based on a rigorous Lyapunov stability analysis and the fixed-time stability criterion, the signals of the closed-loop system are proven to be bounded within a fixed time. Finally, numerical simulations and experiments verified the feasibility of the proposed method.

4.
iScience ; 27(6): 109851, 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38784023

ABSTRACT

The development of tyrosine kinase inhibitors (TKIs) has revolutionarily increased the overall survival of patients with chronic myeloid leukemia (CML). However, drug resistance remains a major obstacle. Here, we demonstrated that a BCR-ABL1-independent long non-coding RNA, IRAIN, is constitutively expressed at low levels in CML, resulting in imatinib resistance. IRAIN knockdown decreased the sensitivity of CD34+ CML blasts and cell lines to imatinib, whereas IRAIN overexpression significantly increased sensitivity. Mechanistically, IRAIN downregulates CD44, a membrane receptor favorably affecting TKI resistance, by binding to the nuclear factor kappa B subunit p65 to reduce the expression of p65 and phosphorylated p65. Therefore, the demethylating drug decitabine, which upregulates IRAIN, combined with imatinib, formed a dual therapy strategy which can be applied to CML with resistance to TKIs.

5.
Front Endocrinol (Lausanne) ; 15: 1294638, 2024.
Article in English | MEDLINE | ID: mdl-38590820

ABSTRACT

As the incidence of type 2 diabetes mellitus (T2DM) is increasing rapidly and its consequences are severe, effective intervention and prevention, including sleep-related interventions, are urgently needed. As a component of sleep architecture, naps, alone or in combination with nocturnal sleep, may influence the onset and progression of T2DM. Overall, napping is associated with an increased risk of T2DM in women, especially in postmenopausal White women. Our study showed that napping >30 minutes (min) increased the risk of T2DM by 8-21%. In addition, non-optimal nighttime sleep increases T2DM risk, and this effect combines with the effect of napping. For nondiabetic patients, napping >30 min could increase the risks of high HbA1c levels and impaired fasting glucose (IFG), which would increase the risk of developing T2DM later on. For diabetic patients, prolonged napping may further impair glycemic control and increase the risk of developing diabetic complications (e.g., diabetic nephropathy) in the distant future. The following three mechanisms are suggested as interpretations for the association between napping and T2DM. First, napping >30 min increases the levels of important inflammatory factors, including interleukin 6 and C-reactive protein, elevating the risks of inflammation, associated adiposity and T2DM. Second, the interaction between postmenopausal hormonal changes and napping further increases insulin resistance. Third, prolonged napping may also affect melatonin secretion by interfering with nighttime sleep, leading to circadian rhythm disruption and further increasing the risk of T2DM. This review summarizes the existing evidence on the effect of napping on T2DM and provides detailed information for future T2DM intervention and prevention strategies that address napping.


Subject(s)
Diabetes Mellitus, Type 2 , Insulin Resistance , Humans , Female , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/epidemiology , Sleep , Circadian Rhythm , Inflammation
6.
J Glob Health ; 14: 04069, 2024 Mar 22.
Article in English | MEDLINE | ID: mdl-38515427

ABSTRACT

Background: China's fertility policy has dramatically changed in the past decade with the successive promulgation of the partial two-child policy, universal two-child policy and three-child policy. The trajectories of maternal and neonatal health accompanied the changes in fertility policy are unknown. Methods: We obtained data of 280 203 deliveries with six common pregnancy complications and thirteen perinatal outcomes between 2010 and 2021 in eastern China. The average annual percent change (AAPC) was calculated to evaluated the temporal trajectories of obstetric characteristics and adverse outcomes during this period. Then, the autoregressive integrated moving average (ARIMA) models were constructed to project future trend of obstetric characteristics and outcomes until 2027. Results: The proportion of advanced maternal age (AMA), assisted reproduction technology (ART) treatment, gestational diabetes mellitus (GDM), anaemia, thrombocytopenia, thyroid dysfunction, oligohydramnios, placental abruption, small for gestational age (SGA) infants, and congenital malformation significantly increased from 2010 to 2021. However, the placenta previa, large for gestational age (LGA) infants and stillbirth significantly decreased during the same period. The AMA and ART treatment were identified as independent risk factors for the uptrends of pregnancy complications and adverse perinatal outcomes. The overall caesarean section rate remained above 40%. Importantly, among multiparas, a previous caesarean section was found to be associated with a significantly reduced risk of hypertensive disorders of pregnancy (HDP), premature rupture of membranes (PROM), placenta previa, placental abruption, perinatal asphyxia, LGA infants, stillbirths, and preterm births. In addition, the ARIMA time series models predicted increasing trends in the ART treatment, GDM, anaemia, thrombocytopenia, postpartum haemorrhage, congenital malformation, and caesarean section until 2027. Conversely, a decreasing trend was predicted for HDP, PROM, and placental abruption premature, LGA infants, SGA infants, perinatal asphyxia, and stillbirth. Conclusions: Maternal and neonatal adverse outcomes became more prevalent from 2010 to 2021 in China. Maternal age and ART treatment were independent risk factors for adverse obstetric outcomes. The findings offered comprehensive trajectories for monitoring pregnancy complications and perinatal outcomes in China, and provided robust intervention targets in obstetric safety. The development of early prediction models and the implementation of prevention efforts for adverse obstetric events are necessary to enhance obstetric safety.


Subject(s)
Abruptio Placentae , Anemia , Placenta Previa , Pregnancy Complications , Premature Birth , Thrombocytopenia , Female , Humans , Infant, Newborn , Pregnancy , Asphyxia , Cesarean Section , Cross-Sectional Studies , Infant Health , Placenta , Placenta Previa/epidemiology , Pregnancy Complications/epidemiology , Pregnancy Outcome/epidemiology , Retrospective Studies , Stillbirth
7.
Sci Rep ; 14(1): 2264, 2024 01 27.
Article in English | MEDLINE | ID: mdl-38278930

ABSTRACT

Multiple myeloma (MM) is a distinguished hematologic malignancy, with existing studies elucidating its interaction with neutrophil extracellular traps (NETs), which may potentially facilitate tumor growth. However, systematic investigations into the role of NETs in MM remain limited. Utilizing the single-cell dataset GSE223060, we discerned active NET cell subgroups, namely neutrophils, monocytes, and macrophages. A transcriptional trajectory was subsequently constructed to comprehend the progression of MM. Following this, an analysis of cellular communication in MM was conducted with a particular emphasis on neutrophils, revealing an augmentation in interactions albeit with diminished strength, alongside abnormal communication links between neutrophils and NK cells within MM samples. Through the intersection of differentially expressed genes (DEGs) between NET active/inactive cells and MM versus healthy samples, a total of 316 genes were identified. This led to the development of a 13-gene risk model for prognostic prediction based on overall survival, utilizing transcriptomics dataset GSE136337. The high-risk group manifested altered immune infiltration and heightened sensitivity to chemotherapy. A constructed nomogram for predicting survival probabilities demonstrated encouraging AUCs for 1, 3, and 5-year survival predictions. Collectively, our findings unveil a novel NET-related prognostic signature for MM, thereby providing a potential avenue for therapeutic exploration.


Subject(s)
Extracellular Traps , Multiple Myeloma , Humans , Multiple Myeloma/genetics , Tumor Microenvironment/genetics , Prognosis , Neutrophils
SELECTION OF CITATIONS
SEARCH DETAIL